跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,727 条关于
“HER2-positive cancers”
全部
96,727
临床试验
78,302
药物
1,906
机构
297
资讯
16,222
3年前
Trastuzumab Deruxtecan Gains Regulatory Approvals in China and Europe for HER2-Positive Cancers
10个月前
Two Novel Tumor-Agnostic Trials Target HER2-Positive Cancers and p53 Mutations at ESMO 2024
11个月前
HUTCHMED Unveils First-in-Class HMPL-A251 Antibody-Targeted Therapy Conjugate with Superior Efficacy Against HER2-Positive Cancers
去年
Meta-Analysis Confirms Trastuzumab Deruxtecan Efficacy in HER2-Positive Gastrointestinal Cancers
2年前
JSKN003 Demonstrates Promising Efficacy in HER2-Positive Cancers and Platinum-Resistant Ovarian Cancer
去年
FDA Approves Zanidatamab (Ziihera®) for HER2-Positive Biliary Tract Cancers
去年
FDA Approves Jazz Pharmaceuticals' Ziihera for HER2-Positive Biliary Tract Cancer
去年
Abpro and Celltrion's ABP-102/CT-P72 Shows Promise as Best-in-Class HER2 T-Cell Engager
9个月前
Abpro and Celltrion Submit IND Application for HER2-Targeting T Cell Engager ABP-102/CT-P72
去年
Phase Ia Study of Novel Anti-HER2 Antibody-Drug Conjugate GQ1001 Shows Promise in Treating HER2 Positive Advanced Solid Tumors
第 1 页,共 1623 页
上一页
下一页